In this context, a recent study has demonstrated that increased invasiveness of chemoresistant pancreatic cancer cells functionally depends on L1CAM.35 It is for these biological reasons that L1CAM is being explored as a therapeutic target in cancer.17 This evidence concerns the gene L1CAM and cancer.